Content area
Full Text
Each abstract has been indexed according to the first author. Abstracts appear as they were submitted and have not undergone editing or the Oncology Nursing Forum's review process. Only abstracts that will be presented appear here. Poster numbers are subject to change. For updated poster numbers, visit congress.ons.org or check the Congress guide.
Data published in abstracts presented at the ONS 44th Annual Congress are embargoed until the conclusion of the presentation. Coverage and/or distribution of an abstract, poster, or any of its supplemental material to or by the news media, any commercial entity, or individuals, including the authors of said abstract, is strictly prohibited until the embargo is lifted. Promotion of general topics and speakers is encouraged within these guidelines.
ADVANCED PRACTICE
1
THE ROLE OF PALLIATIVE CARE IN PHASE 1 CLINICAL TRIAL PARTICIPANTS
Amanda Brock, RN, MSN, MBE, OCN®, Penn Medicine, Philadelphia, PA
There are significant challenges associated with early integration of palliative care in the general oncology setting. Referrals to palliative care are often closer to death than to diagnosis. There is some hope that this pattern will shift as palliative care becomes more integrated into cancer care through initiatives from the IOM, NCCN, and other organizations. These organizations do not specifically address the population of patients enrolled of Phase 1 trials. The challenges of integration of research and clinical care are vast. The purpose of this abstract is to describe an innovative process to provide palliative care simultaneously with a phase one clinical trial. One way to help bridge the gap between research and clinical care is to incorporate Palliative Care Consultation into the enrollment process on a Phase 1 trial. It would take some burden away from the clinical investigator, potentially improve Quality of Life for patients, decrease costs associated with aggressive End of Life care, increase the number of trial participants who have advanced care planning discussions, and provide continuity after trial withdrawal thus decreasing the psychological distress experienced by patients and families near the end of life. Patients with dual enrollment in palliative care and phase 1 trials could live longer lives, remain on trials for longer, have higher rates of advance directive completion, and may be more likely to die comfortably at home. This concept improves the...